Article
Clinical implications of molecular markers in acute myeloid leukemia.
European journal of haematology - 1 Jan 2019
Kayser Sabine, Levis Mark J
Abstract excerpt
The recently updated World Health Organization (WHO) Classification of myeloid neoplasms and leukemia reflects the fact that research in the underlying pathogenic mechanisms of acute myeloid leukemia (AML) has led to remarkable advances in our understanding of the disease. Gene mutations now allow us to explore the enormous diversity among cytogenetically defined subsets of AML, particularly the large subset of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
